Hudock, Inc. Akebia Therapeutics, Inc. Transaction History

Hudock, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$6.67 - $13.58 $2,001 - $4,074	-300 Closed	0 $0
Q4 2019 Jan 21, 2020	SELL	$3.16 - $6.73 $948 - $2,019	-300 Reduced 50.0%	300 $1,000
Q3 2019 Oct 31, 2019	BUY	$3.55 - $5.4 $887 - $1,350	250 Added 71.43%	600 $2,000
Q2 2019 Jul 30, 2019	BUY	$4.1 - $8.05 $1,434 - $2,817	350 New	350 $1,000
Q1 2019 Apr 23, 2019	SELL	$5.41 - $8.73 $1,623 - $2,619	-300 Closed	0 $0
Q3 2018 Oct 16, 2018	SELL	$7.44 - $10.65 $744 - $1,065	-100 Reduced 25.0%	300 $2,000
Q2 2018 Aug 01, 2018	BUY	$9.15 - $11.34 $3,660 - $4,536	400 New	400 $3,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $438M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.